najmaben 8th Aug 2017 at 09:31 pm	very great artical thanks
Ramaswamy Gopalan 7th Aug 2017 at 01:02 am	A timely reminder to Indian drug authorities for introspection.
Anil Pareek 6th Aug 2017 at 11:49 pm	Completely agree, time has come to avoid those companies which are not US FDA compliant. NOOOO quality compromise.
S V Subrahmanyam 6th Aug 2017 at 11:37 am	Trained and skilled employees are not only good for industries but also to the nation. Highly informative... Thankyou for such a nice article
Ajay Vaman Barve 5th Aug 2017 at 10:42 am	Sad but true. I hv spent 32 years in pharma industry. Though Indian pharma exports to the US is fairly good, our manufacturing standards are far below US FDA standards.
Vijay H Dayal 5th Aug 2017 at 09:48 am	Great analysis, not only in terms of investing but also creating awareness about our Indian drug standards.????????
Chandravadan S Maniar 4th Aug 2017 at 08:50 pm	The present dilemma of Indian pharma companies is well caprured. Good article and well articulated.
Raj 4th Aug 2017 at 05:06 pm	Excellent very good observation. What is really important is that to improve upon the ideology "sub kuch chalta hai" I fully back what US FDA is doing.
Nilesh S Raikar 4th Aug 2017 at 04:16 pm	sir your portal is now not only for getting stock recomendations but also turning to be more knolwledge gaining.Thnx for "When US FDA meets Indian Pharmaceutical Companies "
Srinivasan Rangarajan 4th Aug 2017 at 03:12 pm	Good insight of PHARMA working. Thks for bringing to common investor community